A Phase I, Randomized, Blinded, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Doses of MEMP1972A in Volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2012
At a glance
- Drugs Quilizumab (Primary) ; Quilizumab (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions
- 05 Sep 2012 Results presented at the 22nd Annual Congress of the European Respiratory Society.
- 16 Jul 2012 New trial record
- 20 May 2012 Results reported at the 108th International Conference of the American Thoracic Society.